Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients

Journal of B.U.ON.

Volumn 16, Issue 2, 2011, Pages 241-246

  Saip, P ^a   Sen, Fatma ^a   Vural, B ^a   Ugurel, E ^a   Demirkan, A ^a   Derin, D ^a   Eralp, Y ^a   Camlica, H ^a   Ustuner, Z ^b   Ozbek, U ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Ala114Val; GSTP1 polymorphisms; Ile105Val; Platinum based chemotherapy; Small cell lung cancer; Time to tumor progression

Indexed keywords

CISPLATIN; ETOPOSIDE; GLUTATHIONE TRANSFERASE P1;

ADULT; ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; DNA POLYMORPHISM; DRUG DOSE REDUCTION; EXON; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DNA, NEOPLASM; ETOPOSIDE; EXONS; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIOTHERAPY; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960280834     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Educ Health 2003; 16: 230.
2. Al-Hamdan N, Ravichandran K, Al-Sayyad J et al. Incidence of cancer in Gulf Cooperation Council countries, 1998-2001. East Mediterr Health J 2009; 15: 600-611.
3. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003; 41: 245-258. (Pubitemid 36970181)
4. Govindan R, Page N, Morgensztern D et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24: 4539-4544. (Pubitemid 46630948)
5. NCCN Clinical Practice Guidelines in Oncology: non-small cell lung cancer. V.I. 2007. National Comprehensive Cancer Network, 2007.
6. Mascaux C, Paesmans M, Berghmans T et al. European Lung Cancer Working Party (ELCWP). A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000; 30: 23-36.
7. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 1998; 39: 1529-1542. (Pubitemid 28377917)
8. Uchida K. Cellular response to bioactive lipid peroxidation products. Free Radic Res 2000; 33: 731-737. (Pubitemid 32208481)
9. Doulias PT, Kotoglou P, Tenopoulou M et al. Involvement of heat shock protein-70 in the mechanism of hydrogen peroxide-induced DNA damage: the role of lysosomes and iron. Free Radic Biol Med 2007; 42: 567-577. (Pubitemid 46162124)
10. Strange RC, Spiteri MA, Ramachandran S et al. Glutathione-s-transferase family of enzymes. Mutat Res 2001; 482: 21-26.
11. D'Alò F, Voso MT, Guidi F et al. Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 2004; 89: 664-670. (Pubitemid 38828472)
12. Zhang Y, Qu X, Jing W et al. GSTP1 determinescis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling. Anticancer Drugs 2009; 20: 208-214.
13. Bozina N, Bradamante V, Lovrić M. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh Hig Rada Toksikol 2009; 60: 217-242.
14. Srivastava SK, Singhal SS, Hu X et al. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. Arch Biochem Biophys 1999; 366: 89-94. (Pubitemid 29394233)
15. Watson MA, Stewart RK, Smith GB et al. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 275-280. (Pubitemid 28375421)
16. Stewart DJ. Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 2007; 63: 12-31. (Pubitemid 46810280)
17. Godwin AK, Meister A, O'Dwyer PJ et al. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 1992; 89: 3070-3074.
18. Calvert P, Yao KS, Hamilton TC et al. Clinical studies of reversal of drug resistance based on glutathione. Chem Biol Interact 1998; 111-112: 213-224. (Pubitemid 28271946)
19. Booton R, Ward T, Heighway J et al. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer. J Thorac Oncol 2006; 1: 679-683. (Pubitemid 47163956)
20. Sun N, Sun X, Chen B et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 2010; 65: 437-446.
21. Sweeney C, Nazar-Stewart V, Stapleton PL et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev 2003; 12: 527-533.
22. Saip P, Tuzlali S, Demir K et al. Value of glutathione-S-transferase pi as a prognostic factor in epithelial ovarian carcinoma. Eur J Gynaecol Oncol 2005; 26: 90-94. (Pubitemid 40314077)
23. Nelson CP, Kidd LC, Sauvageot J et al. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 2001; 61: 103-109.
24. Martens JE, Smedts F, ter Harmsel B et al. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity. Anticancer Res 1997; 17: 4305-4309.
25. Wang Y, Spitz MR, Schabath MB et al. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer 2003; 40: 25-32. (Pubitemid 36347816)